SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-17-038582
Filing Date
2017-10-13
Accepted
2017-10-13 09:21:39
Documents
5
Period of Report
2017-10-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 22589
2 EXHIBIT 1.1 ex1_1.htm EX-1.1 46514
3 EXHIBIT 4.1 ex4_1.htm EX-4.1 100555
4 EXHIBIT 10.1 ex10_1.htm EX-10.1 204981
5 image0.jpg GRAPHIC 2359
  Complete submission text file 0001140361-17-038582.txt   379230
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 171135759
SIC: 2834 Pharmaceutical Preparations